Moffitt Cancer Center Receives $3.6 Million Grant to Study E-Cigarettes

June 29, 2015

TAMPA, Fla. Moffitt Cancer Center received a $3.6 million grant from the National Institutes of Health to study the use of electronic cigarettes, or e-cigarettes, over the next five years. 

Rather than burning tobacco like traditional cigarettes, e-cigarettes “vaporize” a liquid that usually contains nicotine, and the user inhales the vapor like they would inhale normal cigarette smoke.  The use of e-cigarettes has risen dramatically since their introduction a decade ago.

Although very little is known about the safety of these new products, they are thought to be much less dangerous than conventional cigarettes.  Most e-cigarette users report that they began using the product in an attempt to quit or cut down on smoking. However, there has been little research to date on the effectiveness of e-cigarettes for quitting smoking.

The goal of the new Moffitt grant is to learn how e-cigarettes are used over time, and whether users are eventually successful at quitting smoking.  During the first year of the study, Moffitt researchers will be interviewing e-cigarette users to learn about their experiences and their perceptions of the pros and cons of e-cigarettes.  The researchers want to interview  current and former smokers who are also current or former e-cigarettes users.

According to the lead investigator on the project, Thomas Brandon, Ph.D., director of the Tobacco Research & Intervention Program at Moffitt, “Public health researchers are really playing catch-up with the explosion of e-cigarettes onto the marketplace.” 

During the final four years of the study, Moffitt researchers plan to enroll 2,500 e-cigarette users throughout the United States, and follow them for 24 months by sending them surveys every three months.  The research is expected to provide valuable data about the long-term use of e-cigarettes and their value for quitting smoking.   

“Millions of smokers are using e-cigarettes to try to quit smoking, yet because there is a lack of data, we are not able to advise them whether that is an effective smoking cessation strategy.  This study should provide some answers that will be very useful to smokers as they consider ways to quit,” Brandon explained.

For more information, e-cigarette users interested in being interviewed should call Moffitt’s Tobacco Research and Intervention Program toll-free at 1-877-954-2548.

About Moffitt Cancer Center
Located in Tampa, Moffitt is one of only 41 National Cancer Institute-designated Comprehensive Cancer Centers, a distinction that recognizes Moffitt’s excellence in research, its contributions to clinical trials, prevention and cancer control. Moffitt is the top-ranked cancer hospital in the Southeast and has been listed in U.S. News & World Report as one of the “Best Hospitals” for cancer care since 1999. With more than 4,500 employees, Moffitt has an economic impact in Florida of nearly $1.6 billion. For more information, visit MOFFITT.org, and follow the Moffitt momentum on FacebookTwitter and YouTube.

###